The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
trans-4-(2-(Butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexan-1-ol ID: ALA4878118
PubChem CID: 146403040
Max Phase: Preclinical
Molecular Formula: C27H44N6O
Molecular Weight: 468.69
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCC[C@H](C)Nc1ncc2c(C3CCN(C4CCNCC4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1
Standard InChI: InChI=1S/C27H44N6O/c1-3-4-19(2)30-27-29-17-24-25(18-33(26(24)31-27)22-5-7-23(34)8-6-22)20-11-15-32(16-12-20)21-9-13-28-14-10-21/h17-23,28,34H,3-16H2,1-2H3,(H,29,30,31)/t19-,22-,23-/m0/s1
Standard InChI Key: HQVPUZZSOUVIPN-VJBMBRPKSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
4.3982 -14.1605 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3971 -14.9800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1051 -15.3890 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1033 -13.7516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8119 -14.1569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8122 -14.9755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5909 -15.2283 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0719 -14.5658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5904 -13.9037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8436 -16.0054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2974 -16.6084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5472 -17.3827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3460 -17.5566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8947 -16.9498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6446 -16.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5958 -18.3347 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6890 -15.3881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9816 -14.9789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2736 -15.3869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5662 -14.9778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8582 -15.3858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9823 -14.1617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8460 -13.1301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6466 -12.9616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8996 -12.1883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3555 -11.5782 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5549 -11.7466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2984 -12.5253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6098 -10.8021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4110 -10.6367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6670 -9.8644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1252 -9.2522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3239 -9.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0645 -10.1953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 7 1 1
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
13 16 1 6
2 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
18 22 1 6
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
9 23 1 0
29 30 1 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
26 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 468.69Molecular Weight (Monoisotopic): 468.3577AlogP: 4.44#Rotatable Bonds: 7Polar Surface Area: 78.24Molecular Species: BASEHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.19CX LogP: 3.18CX LogD: 0.01Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.56Np Likeness Score: -0.47
References 1. Zheng H, Zhao J, Li B, Zhang W, Stashko MA, Minson KA, Huey MG, Zhou Y, Earp HS, Kireev D, Graham DK, DeRyckere D, Frye SV, Wang X.. (2021) UNC5293, a potent, orally available and highly MERTK-selective inhibitor., 220 [PMID:34038857 ] [10.1016/j.ejmech.2021.113534 ]